Elisa Agostinetto: Commentary on the updated results of DestinyBreast03

Elisa Agostinetto shared on X/Twitter:

“Out commentary on the updated results of DestinyBreast03 is out on PracticeUpdate, Elsevier.

T-DXd increased PFS of 4 times compared to T-DM1 and increased OS of ~10months.

These results confirm its role as standard of care in 2 line.”

Source: Elisa Agostinetto/X

Dr. Elisa Agostinetto, is a medical oncologist, specializing in breast cancer research. Trained in Milan, Italy, she currently conducts advanced research at Institut Jules Bordet – Université Libre de Bruxelles in Brussels, Belgium.

Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.